Editors:
- Explores pathology in oncologic disease and beyond, into other disease areas that have not received as much attention
- Provides practical wisdom and examples from histopathology experts to apply to drug development programs
- Features techniques, case studies, reviews, and collections of the authors' experiences in the field
Part of the book series: Methods in Pharmacology and Toxicology (MIPT)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (24 protocols)
-
Front Matter
About this book
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development gathers diverse experts to present state of the art guidance and application of histopathology in drug development settings ranging from discovery research to human clinical trials. While many current applications of quantitative histology and molecular pathology in the biopharmaceutical industry are focused on oncology, this volume in addition explores non-oncologic disease areas including nonalcoholic steatohepatitis, arthritis, celiac disease, myeloproliferative disorders, neurology, and wound healing. The authors write from years of experience in diagnostic practice and pharmaceutical drug development, aiming to educate pharmaceutical and academic scientists how to best use tissue to diagnose disease and improve the process of drug development. As part of the Methods in Pharmacology and Toxicology series, this volume is designed to provide wisdom and examples that others can follow and apply as part of drug development.
Comprehensive and practical, Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development will inform and enlighten both tissue-focused and non-tissue-focused drug development professionals about better use and interpretation of the multidimensional data contained in a tissue biopsy.
Editors and Affiliations
-
Flagship Biosciences, LLC, Westminster, USA
Steven J. Potts
-
University of North Carolina, Chapel Hill, USA
David A. Eberhard
-
Novartis Institutes for BioMedical Research, Cambridge, USA
Keith A. Wharton, Jr.
Bibliographic Information
Book Title: Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development
Editors: Steven J. Potts, David A. Eberhard, Keith A. Wharton, Jr.
Series Title: Methods in Pharmacology and Toxicology
DOI: https://doi.org/10.1007/978-1-4939-2681-7
Publisher: Humana New York, NY
eBook Packages: Springer Protocols
Copyright Information: Springer Science+Business Media New York 2015
Hardcover ISBN: 978-1-4939-2680-0Published: 15 June 2015
Softcover ISBN: 978-1-4939-5420-9Published: 29 October 2016
eBook ISBN: 978-1-4939-2681-7Published: 15 June 2015
Series ISSN: 1557-2153
Series E-ISSN: 1940-6053
Edition Number: 1
Number of Pages: XVIII, 375
Number of Illustrations: 20 b/w illustrations, 37 illustrations in colour
Topics: Pharmacology/Toxicology